Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan
台湾全国丙型肝炎登记研究：格卡瑞韦/哌仑他韦通用方案8周治疗初治丙型肝炎患者的真实世界疗效和安全性
期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-024-00968-5
Yang, Chun-Chi; Huang, Chung-Feng; Chang, Te-Sheng; Lo, Ching-Chu; Hung, Chao-Hung; Huang, Chien-Wei; Chong, Lee-Won; Cheng, Pin-Nan; Yeh, Ming-Lun; Peng, Cheng-Yuan; Cheng, Chien-Yu; Huang, Jee-Fu; Bair, Ming-Jong; Lin, Chih-Lang; Yang, Chi-Chieh; Wang, Szu-Jen; Hsieh, Tsai-Yuan; Lee, Tzong-Hsi; Lee, Pei-Lun; Wu, Wen-Chih; Lin, Chih-Lin; Su, Wei-Wen; Yang, Sheng-Shun; Wang, Chia-Chi; Hu, Jui-Ting; Mo, Lein-Ray; Chen, Chun-Ting; Huang, Yi-Hsiang; Chang, Chun-Chao; Huang, Chia-Sheng; Chen, Guei-Ying; Kao, Chien-Neng; Tai, Chi-Ming; Liu, Chun-Jen; Lee, Mei-Hsuan; Kuo, Hsing-Tao; Tsai, Pei-Chien; Dai, Chia-Yen; Kao, Jia-Horng; Lin, Han-Chieh; Chuang, Wang-Long; Tseng, Kuo-Chih; Chen, Chi-Yi; Yu, Ming-Lung
